Amanda Ward, N.D.; Decision and Order
DEA revoked Amanda Ward, N.D.'s registration for failing to maintain effective controls against diversion, signaling heightened scrutiny on naturopathic practitioners handling controlled substances.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 16, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies that fill prescriptions from naturopathic doctors (N.D.s) or similar practitioners with DEA registrations. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately, but formal compliance review within 30 days.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA revoked registration of an N.D. for inadequate diversion controls, reinforcing that all registrants must maintain effective controls or face revocation.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies that fill prescriptions from naturopathic doctors (N.D.s) or similar practitioners with DEA registrations.
What you must do
Review your pharmacy's procedures for verifying prescriber DEA registrations and reporting suspicious orders; ensure you are not filling prescriptions from practitioners with revoked or suspended registrations.
Deadline
Immediately, but formal compliance review within 30 days.
Source: https://www.federalregister.gov/documents/2026/06/24/2026-12652/amanda-ward-nd-decision-and-order
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- IL HB0004: MEDICAID-PHARMACY SERVICES
- Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661
- Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
- Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability
- Mariana Moualem, F.N.P.; Decision and Order